Elevated levels of MIC‐1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Journal of Cancer

• Publication date

  2009-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.24639PMID 19521960
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

  2009cited by this paper
• Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes.

  2009cited by this paper
• Modulation of Angiogenic and Inflammatory Response in Glioblastoma by Hypoxia

  2009cited by this paper
• Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.

  2008cited by this paper
• Expression and putative functions of GDF-15, a member of the TGF-beta superfamily, in human glioma and glioblastoma cell lines.

  2008cited by this paper
• Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction.

  2007cited by this paper
• Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome

  2007cited by this paper
• Progress on molecular markers of pancreatic cancer

  2007cited by this paper
• Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1

  2007cited by this paper
• Serum Macrophage Inhibitory Cytokine-1 Concentrations Correlate with the Presence of Prostate Cancer Bone Metastases

  2007cited by this paper
• Serum GFAP is a diagnostic marker for glioblastoma multiforme.

  2007cited by this paper
• Serum levels of glial fibrillary acidic protein correlate to tumour volume of high‐grade gliomas

  2007cited by this paper
• YKL-40 and Matrix Metalloproteinase-9 as Potential Serum Biomarkers for Patients with High-Grade Gliomas

  2006cited by this paper
• The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.

  2006cited by this paper
• Distinct transcription profiles of primary and secondary glioblastoma subgroups.

  2006cited by this paper
• Measurement of Serum Levels of Macrophage Inhibitory Cytokine 1 Combined with Prostate-Specific Antigen Improves Prostate Cancer Diagnosis

  2006cited by this paper
• Identification of novel target genes by an epigenetic reactivation screen of renal cancer.

  2006cited by this paper
• Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer.

  2006cited by this paper
• Common cancer biomarkers.

  2006cited by this paper
• Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions

  2005cited by this paper
• CD163‐positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation

  2005cited by this paper
• High Serum Levels of Matrix Metalloproteinase-9 and Matrix Metalloproteinase-1 Are Associated with Rapid Progression in Patients with Metastatic Melanoma

  2005cited by this paper
• Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays

  2005cited by this paper
• MGMT gene silencing and benefit from temozolomide in glioblastoma.

  2005cited by this paper
• Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients

  2004cited by this paper
• Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage.

  2004cited by this paper
• Early detection and prognosis of ovarian cancer using serum YKL-40.

  2004cited by this paper
• MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma.

  2003cited by this paper
• Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues

  2003cited by this paper
• Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.

  2003cited by this paper
• Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

  2003cited by this paper
• NF-kappaB in cancer: from innocent bystander to major culprit.

  2002cited by this paper
• Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1

  2002cited by this paper
• NF-κB in cancer: from innocent bystander to major culprit

  2002cited by this paper
• Antibody-based approach to high-volume genotyping for MIC-1 polymorphism.

  2002cited by this paper
• Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities.

  2001cited by this paper
• Cyclooxygenase Inhibitors Regulate the Expression of a TGF-β Superfamily Member That Has Proapoptotic and Antitumorigenic Activities

  2001cited by this paper
• Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells.

  2001cited by this paper
• Profile of gene expression regulated by induced p53: connection to the TGF‐β family

  2000cited by this paper
• The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women.

  2000cited by this paper
• Growth/Differentiation Factor-15/Macrophage Inhibitory Cytokine-1 Is a Novel Trophic Factor for Midbrain Dopaminergic Neurons In Vivo

  2000cited by this paper
• Placental Transforming Growth Factor-β Is a Downstream Mediator of the Growth Arrest and Apoptotic Response of Tumor Cells to DNA Damage and p53 Overexpression*

  2000cited by this paper
• MIC‐1 is a novel TGF‐β superfamily cytokine associated with macrophage activation

  1999cited by this paper
• Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein Family*

  1998cited by this paper
• PLAB, a novel placental bone morphogenetic protein.

  1997cited by this paper
• MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily.

  1997influential reference
• Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta.

  1997cited by this paper
• Contribution neuroanesthésique à la prévention des complications de la rétraction cérébrale mécanique: le concept de l'écarteur chimique*

  1995cited by this paper
• [Neuro-anesthetic contribution to the prevention of complications caused by mechanical cerebral retraction: concept of a chemical brain retractor].

  1995cited by this paper
• Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)

  1976cited by this paper

• 3D heterotypic models of glioblastoma reveal the impact of microglia on cellular organization and the production of a distinct secretome

  2026cites this paper
• Growth differentiation factor 15 aggravates sepsis-induced cognitive and memory impairments by promoting microglial inflammatory responses and phagocytosis

  2025cites this paper
• Comprehensive Evaluation of Frailty and Sarcopenia Markers to Predict Survival in Glioblastoma Patients

  2025cites this paper
• Growth and differentiation factor 15: An emerging therapeutic target for brain diseases.

  2025cites this paper
• New Horizons with Growth Differentiation Factor 15 in Oncology: From Cancer Cachexia and Tumour Immunity to Novel Therapeutic Strategies

  2025cites this paper
• What Is the Potential Relevance of Growth and Differentiation Factor-15 in Neurologic Disease?

  2025cites this paper
• Decoding cancer insights: recent progress and strategies in proteomics for biomarker discovery

  2024cites this paper
• ZBTB18 regulates cytokine expression and affects microglia/macrophage recruitment and commitment in glioblastoma

  2024cites this paper
• Interleukin 4 and cancer resistance in glioblastoma multiforme

  2024cites this paper
• Biomarkers in Cerebrospinal Fluid for the Diagnosis and Monitoring of Gliomas

  2024cites this paper
• Macrophages as a Source and Target of GDF-15

  2024cites this paper
• Microglia in Glioblastomas: Molecular Insight and Immunotherapeutic Potential

  2024cites this paper
• Growth/differentiation factor 15 controls number of ependymal and neural stem cells in the ventricular-subventricular zone

  2023cites this paper
• Overexpression of Growth Differentiation Factor 15 in Glioblastoma Stem Cells Promotes Their Radioresistance

  2023cites this paper
• Immunotherapeutic Approaches for Glioblastoma Treatment

  2022cites this paper
• Growth differentiation factor-15 overexpression promotes cell proliferation and predicts poor prognosis in cerebral lower-grade gliomas correlated with hypoxia and glycolysis signature.

  2022cites this paper
• Weighted Gene Co-Expression Network Analysis and Support Vector Machine Learning in the Proteomic Profiling of Cerebrospinal Fluid from Extraventricular Drainage in Child Medulloblastoma

  2022cites this paper
• Proteome and secretome analysis of pancreatic cancer cells

  2022cites this paper
• GDF15 expression in glioma is associated with malignant progression, immune microenvironment, and serves as a prognostic factor

  2021cites this paper
• GDF15 promotes glioma stem cell-like phenotype via regulation of ERK1/2–c-Fos–LIF signaling

  2021cites this paper
• GDF‐15: Diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme

  2021influential citation
• Growth differentiation factor 15 increases in both cerebrospinal fluid and serum during pregnancy

  2021cites this paper
• Transcriptomics-Based Phenotypic Screening Supports Drug Discovery in Human Glioblastoma Cells

  2021cites this paper
• Computational Screening of Secretory Proteins With Brain-Specific Expression in Glioblastoma Multiforme

  2021cites this paper
• Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery

  2021cites this paper
• Older adults with frailty syndrome present an altered platelet function and an increased level of circulating oxidative stress and mitochondrial dysfunction biomarker GDF-15.

  2020cites this paper
• INTRATUMORAL HETEROGENEITY IN GLIOBLASTOMA: SUBTYPE TRANSITION AND CELL-TO-CELL COMMUNICATION

  2020cites this paper
• The Role of GDF15 in Regulating the Canonical Pathways of the Tumor Microenvironment in Wild-Type p53 Ovarian Tumor and Its Response to Chemotherapy

  2020cites this paper
• Growth differentiation factor 15 (GDF15) in cancer cell metastasis: from the cells to the patients

  2020cites this paper
• Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint

  2020cites this paper
• Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma.

  2020cites this paper
• Solid stress-induced migration is mediated by GDF15 through Akt pathway activation in pancreatic cancer cells

  2019cites this paper
• Growth differentiation factor 15 and its role in carcinogenesis: an update

  2019cites this paper
• Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases.

  2019cites this paper
• Growth and differentiation factor 15 regulates PD-L1 expression in glioblastoma

  2019cites this paper
• GDF15 secreted by senescent endothelial cells improves vascular progenitor cell functions

  2019cites this paper
• Muscle wasting in the presence of disease, why is it so variable?

  2018cites this paper
• GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer

  2018cites this paper
• Solid Stress Facilitates Fibroblasts Activation to Promote Pancreatic Cancer Cell Migration

  2018cites this paper
• Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines

  2018cites this paper
• Elevated growth differentiating factor 15 expression predicts long-term benefit of docetaxel, cisplatin and 5-fluorouracil induction chemotherapy in patients with oral cancer.

  2018cites this paper
• Astrocytes, the rising stars of the glioblastoma microenvironment

  2018cites this paper
• Proteomics and Biomarkers Based Diagnosis of Brain Tumor: A Review

  2018cites this paper
• Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis

  2017cites this paper
• Cerebrospinal fluid biomarkers of malignancies located in the central nervous system.

  2017cites this paper
• Plasma GDF15 level is elevated in psychosis and inversely correlated with severity

  2017cites this paper
• Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread

  2017cites this paper
• Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients

  2016cites this paper
• GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia

  2016cites this paper
• Integrated Molecular Epidemiology of Colorectal Cancer: An Exploration of Chronic Inflammation and the Gut Microbiome

  2016cites this paper
• Targeting cerebrospinal fluid for discovery of brain cancer biomarkers

  2016cites this paper
• Biomarkers for diet in cancer prevention studies

  2016cites this paper
• Macrophage Inhibitory Cytokine-1 as a Novel Diagnostic and Prognostic Biomarker in Stage I and II Nonsmall Cell Lung Cancer

  2016cites this paper
• Control of glioma cell migration and invasiveness by GDF-15

  2016cites this paper
• Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age‐related disorders

  2016cites this paper
• Macrophage inhibitory cytokine-1/growth differentiation factor 15 as a marker of cognitive ageing and dementia

  2016cites this paper
• GDF 15 - A Novel Biomarker in the Offing for Heart Failure

  2016cites this paper
• Transforming growth factor β and bone morphogenetic protein actions in brain tumors

  2015cites this paper
• Liquid biopsies in patients with diffuse glioma

  2015cites this paper
• Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.

  2015cites this paper
• New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection

  2015cites this paper
• Mechanisms of BMP-Receptor Interaction and Activation.

  2015cites this paper
• Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

  2015cites this paper
• Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.

  2015cites this paper
• Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies

  2015cites this paper
• Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells

  2015cites this paper
• The Relationship of Serum Macrophage Inhibitory Cytokine – 1 Levels with Gray Matter Volumes in Community-Dwelling Older Individuals

  2015cites this paper
• Diagnostic Performance of Serum Macrophage Inhibitory Cytokine-1 in Pancreatic Cancer: A Meta-Analysis and Meta-Regression Analysis

  2014cites this paper
• Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer.

  2014cites this paper
• Opposing Effects of PI3K/Akt and Smad-Dependent Signaling Pathways in NAG-1-Induced Glioblastoma Cell Apoptosis

  2014cites this paper
• Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15.

  2014cites this paper
• Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.

  2014cites this paper
• GDF-15 deficiency induces a progressive Schwann cell loss in vivo and regulates their survival and migration in vitro

  2013cites this paper
• Potentials of Plasma NGAL and MIC-1 as Biomarker(s) in the Diagnosis of Lethal Pancreatic Cancer

  2013cites this paper
• Macrophage inhibitory cytokine‐1 is associated with cognitive impairment and predicts cognitive decline – the Sydney Memory and Aging Study

  2013cites this paper
• Proteasome inhibitor MG132 induces NAG-1/GDF15 expression through the p38 MAPK pathway in glioblastoma cells.

  2013cites this paper
• Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis

  2013cites this paper
• Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) Slows Cancer Development but Increases Metastases in TRAMP Prostate Cancer Prone Mice

  2012cites this paper
• Growth/differentiation factor-15: prostate cancer suppressor or promoter?

  2012cites this paper
• Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid.

  2012cites this paper
• Diagnostic markers for glioblastoma.

  2011cites this paper
• Glioblastoma Multiforme Stem Cells

  2011cites this paper
• Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older Adults The left left

  2011cites this paper
• Review Diagnostic markers for glioblastoma

  2011cites this paper
• The TGF-β superfamily cytokine, MIC-1/GDF15: A pleotrophic cytokine with roles in inflammation, cancer and metabolism

  2011influential citation
• Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older Adults: The Rancho Bernardo Study

  2011cites this paper
• Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?

  2010cites this paper
• Expression and Clinical Role of Growth Differentiation Factor-15 in Ovarian Carcinoma Effusions

  2010cites this paper
• Glioma cancer stem cells induce immunosuppressive macrophages/microglia.

  2010cites this paper
• GDF-15 Contributes to Proliferation and Immune Escape of Malignant Gliomas

  2010influential citation
• Analysis of stroma-derived factors with potential prognostic and therapeutic significance in prostate cancer

  2010cites this paper
• Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer

  2010cites this paper
• The effect of full length and mature NAG-1 protein overexpression on cytotoxicity of celecoxib, tamoxifen and doxorubicin in HT1080

  2010cites this paper
• Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine‐1 in cancer

  2010cites this paper
• Molecular tools: biology, prognosis, and therapeutic triage.

  2010cites this paper
• A systematic review of CSF biomarker discovery in neuro-oncology: A roadmap to standardization and clinical application

  year unknowncites this paper